James H. Reamer

Array ( [id] => 4296503 [patent_doc_number] => 06197828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Derivatives of (+)-venlafaxine and methods of preparing and using the same' [patent_app_type] => 1 [patent_app_number] => 9/450691 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12488 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197828.pdf [firstpage_image] =>[orig_patent_app_number] => 450691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237181 [patent_doc_number] => 06143725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 9/424207 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11261 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143725.pdf [firstpage_image] =>[orig_patent_app_number] => 424207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384365 [patent_doc_number] => 06262111 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Method for increasing the concentration of ascorbic acid in brain tissues of a subject' [patent_app_type] => 1 [patent_app_number] => 9/449516 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 10047 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262111.pdf [firstpage_image] =>[orig_patent_app_number] => 449516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420713 [patent_doc_number] => 06177433 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'JAK-3 inhibitors for treating allergic disorders' [patent_app_type] => 1 [patent_app_number] => 9/443847 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 53 [patent_no_of_words] => 20609 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177433.pdf [firstpage_image] =>[orig_patent_app_number] => 443847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249679 [patent_doc_number] => 06221904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Method for increasing the concentration of ascorbic acid in brain tissues of a subject' [patent_app_type] => 1 [patent_app_number] => 9/443785 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 6269 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221904.pdf [firstpage_image] =>[orig_patent_app_number] => 443785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350037 [patent_doc_number] => 06214819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method for treating ocular neovascular diseases' [patent_app_type] => 1 [patent_app_number] => 9/442781 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4116 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214819.pdf [firstpage_image] =>[orig_patent_app_number] => 442781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192573 [patent_doc_number] => 06130216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Use of thiazolidinedione derivatives in the treatment of insulin resistance' [patent_app_type] => 1 [patent_app_number] => 9/440997 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12157 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130216.pdf [firstpage_image] =>[orig_patent_app_number] => 440997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249764 [patent_doc_number] => 06221909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Method for supplying bioavailable methionine to a cow' [patent_app_type] => 1 [patent_app_number] => 9/438521 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5573 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221909.pdf [firstpage_image] =>[orig_patent_app_number] => 438521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4127121 [patent_doc_number] => 06127363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction' [patent_app_type] => 1 [patent_app_number] => 9/437999 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10361 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127363.pdf [firstpage_image] =>[orig_patent_app_number] => 437999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157889 [patent_doc_number] => 06156753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction' [patent_app_type] => 1 [patent_app_number] => 9/437682 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9009 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156753.pdf [firstpage_image] =>[orig_patent_app_number] => 437682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296098 [patent_doc_number] => 06184230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Anti-helicobacter pylori pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 9/423924 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3386 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184230.pdf [firstpage_image] =>[orig_patent_app_number] => 423924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296359 [patent_doc_number] => 06184248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Compositions and methods for treatment of neurological disorders and neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 9/435470 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 36 [patent_no_of_words] => 15945 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184248.pdf [firstpage_image] =>[orig_patent_app_number] => 435470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533006 [patent_doc_number] => 06410524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease' [patent_app_type] => B1 [patent_app_number] => 09/434685 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 11363 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410524.pdf [firstpage_image] =>[orig_patent_app_number] => 09434685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153292 [patent_doc_number] => 06767925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-27 [patent_title] => 'Sprayable analgesic composition and method of use' [patent_app_type] => B1 [patent_app_number] => 09/431647 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1008 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767925.pdf [firstpage_image] =>[orig_patent_app_number] => 09431647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252436 [patent_doc_number] => 06207683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Benzocycloheptathiophene compounds' [patent_app_type] => 1 [patent_app_number] => 9/381351 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7245 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207683.pdf [firstpage_image] =>[orig_patent_app_number] => 381351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142260 [patent_doc_number] => 20020002180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'ANTIVIRAL COMBINATIONS' [patent_app_type] => new [patent_app_number] => 09/429863 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4718 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002180.pdf [firstpage_image] =>[orig_patent_app_number] => 09429863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158061 [patent_doc_number] => 06156764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type' [patent_app_type] => 1 [patent_app_number] => 9/137078 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2782 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156764.pdf [firstpage_image] =>[orig_patent_app_number] => 137078 [rel_patent_id] =>[rel_patent_doc_number] =>)